# Clinical Study of Bivalirudin for Percutaneous Coronary Intervention (PCI)

> **NCT03567408** · PHASE2 · UNKNOWN · sponsor: **Qian Gong** · enrollment: 200 (estimated)

## Conditions studied

- Coronary Heart Disease

## Interventions

- **PROCEDURE:** Selective PCI
- **DRUG:** Bivalirudin

## Key facts

- **NCT ID:** NCT03567408
- **Lead sponsor:** Qian Gong
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-09-15
- **Primary completion:** 2019-08-12
- **Final completion:** 2020-08-12
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2018-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03567408

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03567408, "Clinical Study of Bivalirudin for Percutaneous Coronary Intervention (PCI)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03567408. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*